11:28 AM EDT, 09/10/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were moving sharply lower late Tuesday morning, falling 1.21% to 1,404.91 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies ( DBVT ) and biotech firm BioNTech (BNTX), which rose 2.6% and 2.3%, respectively. They were followed by semiconductor company Sequans Communications ( SQNS ) and furniture maker Natuzzi (NTZ), which were down 1.5% and 1.4%, respectively.

The decliners from continental Europe were led by telecommunications company VEON (VEON) and medical device maker EDAP TMS ( EDAP ) , which retreated 6.9% and 3.5%, respectively. Biopharmaceutical firm Grifols ( GRFS ) lost 3.3% and financial services company Banco Santander (SAN) was down 2.8%.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and TC Biopharm ( TCBP ) , which advanced 8.5% and 3.9%, respectively. They were followed by biopharmaceutical companies Bicycle Therapeutics (BCYC) and Mereo BioPharma Group (MREO), which rose 3.6% and 2.3%, respectively.

The decliners from the UK and Ireland were led by financial services companies Barclays ( JJCTF ) and Lloyds Banking Group ( LYG ) , which fell 3% and 2.8%, respectively. Biopharmceutical company NuCana ( NCNA ) was down 2.6% and financial services company HSBC ( HSBC ) lost 2.3%.